Includes BIIB, GENZ Legendary activist investor, Carl Icahn, has made some big bets in the biotechnology sector. Two of his largest holdings are Genzyme (NASDAQ: GENZ) and Biogen Idec (NASDAQ: BIIB). Icahn's position in GENZ is worth around $235 million. His investment ...
Privately held Vanguard Health plans to buy nonprofit, 8-hospital Detroit Medical Center Detroit Medical Center officials said Friday that plans for the nonprofit hospital system to be purchased by the privately held Vanguard Health Systems Inc. will allow it to maintain its ...
The Food and Drug Administration said Friday the highest available dose of Zocor, a component in cholesterol drugs, can cause muscle damage as well as severe and potentially lethal kidney damage. The agency said statin drugs like Zocor are known to cause ...
LONDON (Reuters) - Barriers to understanding pain are starting to fall and scientists and drug firms say a fresh approach is producing potential new drugs to hit where it hurts. Millions of people across the world suffer chronic pain -- such as ...
CHICAGO (Reuters) - Virtually all of the experts who wrote favorably about GlaxoSmithKline Plc's troubled diabetes drug Avandia had financial ties to drug makers, a finding that shows the need for reform of such relationships, U.S. researchers said on Thursday. A team ...
WASHINGTON (Reuters) - U.S. regulators, drug companies, philanthropists and advocates announced a new alliance on Thursday to speed tuberculosis drugs to market, a day after cancer researchers and drugmakers launched a similar initiative. The U.S. Food and Drug Administration said it will ...
AstraZeneca PLC's blockbuster psychiatric drug Seroquel did not trigger diabetes in a Vietnam veteran, a jury ruled Thursday in the first trial out of thousands of cases alleging the powerful drug caused diabetes. The British drugmaker said a jury in Middlesex County ...
WASHINGTON (Reuters) - Novartis AG and Astellas Pharma eczema drugs may need their warning labels expanded after dozens of new reported cases of cancer and infection in children, U.S. Food and Drug Administration staff said in documents released on Thursday. Agency scientists ...
LONDON (Reuters) - It's been a bad month for Pfizer's <PFE.N> research labs but its head of R&D says the world's biggest drugmaker is on track to hit earlier targets for new drug filings despite the setbacks. "We have had some disappointments, ...
NEW YORK/LONDON (Reuters) - AstraZeneca Plc <AZN.L> won a U.S. court battle on Thursday over product liability claims for its blockbuster Seroquel schizophrenia treatment, the first such case to go to trial. Thousands of plaintiffs have filed lawsuits claiming that Seroquel caused ...
